{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:29:08Z","timestamp":1772202548689,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,7]]},"DOI":"10.7759\/cureus.83653","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T12:19:06Z","timestamp":1746620346000},"source":"Crossref","is-referenced-by-count":3,"title":["Evidence-Based Review by a Multidisciplinary Team of Pediatricians on the Use of Gastric Acid-Reducing Medications in Children: Indian Perspectives"],"prefix":"10.7759","author":[{"given":"Udai A","family":"Pai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.V.","family":"Ravishankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalit","family":"Bharadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somashekara","family":"H.R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Wadhwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baldev","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayakumar","family":"C.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hrishikesh","family":"Belsare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanav","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthick","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khuzema","family":"Furniturewala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Sanklecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mylapore   V","family":"Suresh Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyali","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prahlad","family":"N.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod","family":"Jog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Wazir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh T","family":"Soans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreenath  S","family":"Manikanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashis","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhashish","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utkarsh","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v3.i6.93","article-title":"Use of acid suppressive therapy in hospitalized non-critically ill patients","volume":"3","author":"Sheikh-Taha M","year":"2012","unstructured":"Sheikh-Taha M, Alaeddine S, Nassif J. Use of acid suppressive therapy in hospitalized non-critically ill patients. World J Gastrointest Pharmacol Ther. 2012, 3:93-6. 10.4292\/wjgpt.v3.i6.93","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3928\/00904481-20140325-12","article-title":"Functional dyspepsia in children","volume":"43","author":"Ganesh M","year":"2014","unstructured":"Ganesh M, Nurko S. Functional dyspepsia in children. Pediatr Ann. 2014, 43:e101-5. 10.3928\/00904481-20140325-12","journal-title":"Pediatr Ann"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000002202","article-title":"Stress ulcer prophylaxis in critically ill children: a multicenter observational study","volume":"21","author":"Duffett M","year":"2020","unstructured":"Duffett M, Chan A, Closs J, et al.. Stress ulcer prophylaxis in critically ill children: a multicenter observational study. Pediatr Crit Care Med. 2020, 21:e107-13. 10.1097\/PCC.0000000000002202","journal-title":"Pediatr Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2012.01.005","article-title":"Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule","volume":"65","author":"Puig I","year":"2012","unstructured":"Puig I, Calzado S, Su\u00e1rez D, S\u00e1nchez-Delgado J, L\u00f3pez S, Calvet X. Meta-analysis: comparative efficacy of H2-receptor antagonists and proton pump inhibitors for reducing aspiration risk during anaesthesia depending on the administration route and schedule. Pharmacol Res. 2012, 65:480-90. 10.1016\/j.phrs.2012.01.005","journal-title":"Pharmacol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.24917","article-title":"Gastroesophageal reflux disease and asthma: a narrative review","volume":"14","author":"Grandes XA","year":"2022","unstructured":"Grandes XA, Talanki Manjunatha R, Habib S, Sangaraju SL, Yepez D. Gastroesophageal reflux disease and asthma: a narrative review. Cureus. 2022, 14:e24917. 10.7759\/cureus.24917","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.21037\/tp-22-401","article-title":"Clinical use of gastric antisecretory drugs in pediatric patients with gastroesophageal reflux disease: a narrative review","volume":"12","author":"Cuzzolin L","year":"2023","unstructured":"Cuzzolin L, Locci C, Chicconi E, Antonucci R. Clinical use of gastric antisecretory drugs in pediatric patients with gastroesophageal reflux disease: a narrative review. Transl Pediatr. 2023, 12:260-70. 10.21037\/tp-22-401","journal-title":"Transl Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.18203\/2349-3291.ijcp20222434","article-title":"Ranitidine use in pediatrics: current evidence-based review and recommendations","volume":"9","author":"Pai UA","year":"2022","unstructured":"Pai UA, Kesavelu D, Shah AK, et al.. Ranitidine use in pediatrics: current evidence-based review and recommendations. Int J Contemp Pediatr. 2022, 9:987. 10.18203\/2349-3291.ijcp20222434","journal-title":"Int J Contemp Pediatr"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-2625","article-title":"Early acid suppression therapy exposure and fracture in young children","volume":"144","author":"Malchodi L","year":"2019","unstructured":"Malchodi L, Wagner K, Susi A, Gorman G, Hisle-Gorman E. Early acid suppression therapy exposure and fracture in young children. Pediatrics. 2019, 144:10.1542\/peds.2018-2625","journal-title":"Pediatrics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000858","article-title":"Potassium-competitive acid blockers and acid-related disorders","volume":"31","author":"Huang KZ","year":"2024","unstructured":"Huang KZ, Weber HC. Potassium-competitive acid blockers and acid-related disorders. Curr Opin Endocrinol Diabetes Obes. 2024, 31:107-14. 10.1097\/MED.0000000000000858","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-0909","article-title":"Acid suppression therapy and symptom improvement (or lack thereof) in children","volume":"144","author":"Boruta M","year":"2019","unstructured":"Boruta M, Boruta R, Li J. Acid suppression therapy and symptom improvement (or lack thereof) in children. Pediatrics. 2019, 144:10.1542\/peds.2019-0909","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-021-03854-x","article-title":"Inappropriate prescribing of proton pump inhibitors in children: insights from a survey","volume":"88","author":"Yadav R","year":"2021","unstructured":"Yadav R, Bolia R, Bhat NK. Inappropriate prescribing of proton pump inhibitors in children: insights from a survey. Indian J Pediatr. 2021, 88:1055. 10.1007\/s12098-021-03854-x","journal-title":"Indian J Pediatr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10018-1430","article-title":"Multidisciplinary consensus for rationalizing the use of acid suppressants in children and adults: CONFOR","volume":"14","author":"Prabhoo RY","year":"2024","unstructured":"Prabhoo RY, Pai UA, Wadhwa A, et al.. Multidisciplinary consensus for rationalizing the use of acid suppressants in children and adults: CONFOR. Euroasian J Hepatogastroenterol. 2024, 14:99-119. 10.5005\/jp-journals-10018-1430","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2018.12.012","article-title":"GERD in the NICU infant: who needs to be treated and what approach is beneficial?","volume":"66","author":"Gulati IK","year":"2019","unstructured":"Gulati IK, Jadcherla SR. GERD in the NICU infant: who needs to be treated and what approach is beneficial?. Pediatr Clin North Am. 2019, 66:461-73. 10.1016\/j.pcl.2018.12.012","journal-title":"Pediatr Clin North Am"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181fea0a9","article-title":"Value of the Likert dyspepsia scale in differentiation of functional and organic dyspepsia in children","volume":"52","author":"Canan O","year":"2011","unstructured":"Canan O, Ozcay F, Ozbay-Hosnut F, Yazici C, Bilezikci B. Value of the Likert dyspepsia scale in differentiation of functional and organic dyspepsia in children. J Pediatr Gastroenterol Nutr. 2011, 52:392-8. 10.1097\/MPG.0b013e3181fea0a9","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.839972","article-title":"A narrative review on efficacy and safety of proton pump inhibitors in children","volume":"13","author":"Dipasquale V","year":"2022","unstructured":"Dipasquale V, Cicala G, Spina E, Romano C. A narrative review on efficacy and safety of proton pump inhibitors in children. Front Pharmacol. 2022, 13:839972. 10.3389\/fphar.2022.839972","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v7.i4.531","article-title":"Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?","volume":"7","author":"Safe M","year":"2016","unstructured":"Safe M, Chan WH, Leach ST, Sutton L, Lui K, Krishnan U. Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?. World J Gastrointest Pharmacol Ther. 2016, 7:531-9. 10.4292\/wjgpt.v7.i4.531","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5863\/1551-6776-19.4.283","article-title":"Proton pump inhibitor prescribing patterns in newborns and infants","volume":"19","author":"Illueca M","year":"2014","unstructured":"Illueca M, Alemayehu B, Shoetan N, Yang H. Proton pump inhibitor prescribing patterns in newborns and infants. J Pediatr Pharmacol Ther. 2014, 19:283-7. 10.5863\/1551-6776-19.4.283","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-019-1549-8","article-title":"Acid suppression in neonates: friend or foe?","volume":"56","author":"Murthy P","year":"2019","unstructured":"Murthy P, Dosani A, Lodha A. Acid suppression in neonates: friend or foe?. Indian Pediatr. 2019, 56:541-6. 10.1007\/s13312-019-1549-8","journal-title":"Indian Pediatr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03855-6","article-title":"Prescription of acid inhibitors in infants: an addiction hard to break","volume":"179","author":"Levy EI","year":"2020","unstructured":"Levy EI, Salvatore S, Vandenplas Y, de Winter JP. Prescription of acid inhibitors in infants: an addiction hard to break. Eur J Pediatr. 2020, 179:1957-61. 10.1007\/s00431-020-03855-6","journal-title":"Eur J Pediatr"},{"key":"ref20","article-title":"API-ISG Consensus guidelines for management of gastrooesophageal reflux disease","volume":"68","author":"Bhatia S","year":"2020","unstructured":"Bhatia S, Pareek KK, Kumar A, et al.. API-ISG Consensus guidelines for management of gastrooesophageal reflux disease. J Assoc Physicians India. 2020, 68:69-80.","journal-title":"J Assoc Physicians India"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15213","article-title":"The effects of proton pump inhibitors on the microbiome in young children","volume":"109","author":"Levy EI","year":"2020","unstructured":"Levy EI, Hoang DM, Vandenplas Y. The effects of proton pump inhibitors on the microbiome in young children. Acta Paediatr. 2020, 109:1531-8. 10.1111\/apa.15213","journal-title":"Acta Paediatr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ432","article-title":"Use of acid suppression medication is associated with risk for C. difficile infection in infants and children: a population-based study","volume":"61","author":"Freedberg DE","year":"2015","unstructured":"Freedberg DE, Lamous\u00e9-Smith ES, Lightdale JR, Jin Z, Yang YX, Abrams JA. Use of acid suppression medication is associated with risk for C. difficile infection in infants and children: a population-based study. Clin Infect Dis. 2015, 61:912-7. 10.1093\/cid\/civ432","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2023.2900","article-title":"Proton pump inhibitor use and risk of serious infections in young children","volume":"177","author":"Lassalle M","year":"2023","unstructured":"Lassalle M, Zureik M, Dray-Spira R. Proton pump inhibitor use and risk of serious infections in young children. JAMA Pediatr. 2023, 177:1028-38. 10.1001\/jamapediatrics.2023.2900","journal-title":"JAMA Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.0007","article-title":"Association between proton pump inhibitor use and risk of fracture in children","volume":"174","author":"Wang YH","year":"2020","unstructured":"Wang YH, Wintzell V, Ludvigsson JF, Svanstr\u00f6m H, Pasternak B. Association between proton pump inhibitor use and risk of fracture in children. JAMA Pediatr. 2020, 174:543-51. 10.1001\/jamapediatrics.2020.0007","journal-title":"JAMA Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0315","article-title":"Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood","volume":"172","author":"Mitre E","year":"2018","unstructured":"Mitre E, Susi A, Kropp LE, Schwartz DJ, Gorman GH, Nylund CM. Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood. JAMA Pediatr. 2018, 172:e180315. 10.1001\/jamapediatrics.2018.0315","journal-title":"JAMA Pediatr"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00775-y","article-title":"Dysbiosis of the gut and lung microbiome has a role in asthma","volume":"42","author":"Hufnagl K","year":"2020","unstructured":"Hufnagl K, Pali-Sch\u00f6ll I, Roth-Walter F, Jensen-Jarolim E. Dysbiosis of the gut and lung microbiome has a role in asthma. Semin Immunopathol. 2020, 42:75-93. 10.1007\/s00281-019-00775-y","journal-title":"Semin Immunopathol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.5710","article-title":"Association between proton pump inhibitor use and risk of asthma in children","volume":"175","author":"Wang YH","year":"2021","unstructured":"Wang YH, Wintzell V, Ludvigsson JF, Svanstr\u00f6m H, Pasternak B. Association between proton pump inhibitor use and risk of asthma in children. JAMA Pediatr. 2021, 175:394-403. 10.1001\/jamapediatrics.2020.5710","journal-title":"JAMA Pediatr"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/IMNA-D-22-00027","article-title":"Research progress on the potential mechanisms of acute kidney injury and chronic kidney disease induced by proton pump inhibitors","volume":"10","author":"Song Z","year":"2023","unstructured":"Song Z, Gong X. Research progress on the potential mechanisms of acute kidney injury and chronic kidney disease induced by proton pump inhibitors. Integr Med Nephrol Androl. 2023, 10:00027. 10.1097\/IMNA-D-22-00027","journal-title":"Integr Med Nephrol Androl"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-2284","article-title":"Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children","volume":"8","author":"Li Y","year":"2020","unstructured":"Li Y, Xiong M, Yang M, et al.. Proton pump inhibitors and the risk of hospital-acquired acute kidney injury in children. Ann Transl Med. 2020, 8:1438. 10.21037\/atm-20-2284","journal-title":"Ann Transl Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1891\/0730-0832.37.1.33","article-title":"Acid suppression for gastroesophageal reflux disease in infants","volume":"37","author":"Rostas SE","year":"2018","unstructured":"Rostas SE, McPherson C. Acid suppression for gastroesophageal reflux disease in infants. Neonatal Netw. 2018, 37:33-41. 10.1891\/0730-0832.37.1.33","journal-title":"Neonatal Netw"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.86","article-title":"Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design","volume":"92","author":"Shakhnovich V","year":"2012","unstructured":"Shakhnovich V, Ward RM, Kearns GL. Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design. Clin Pharmacol Ther. 2012, 92:388-92. 10.1038\/clpt.2012.86","journal-title":"Clin Pharmacol Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/apa.17074","article-title":"Infant gastroesophageal reflux disease management consensus","volume":"113","author":"Vandenplas Y","year":"2024","unstructured":"Vandenplas Y, Orsi M, Benninga M, Gatcheco F, Rosen R, Thomson M. Infant gastroesophageal reflux disease management consensus. Acta Paediatr. 2024, 113:403-10. 10.1111\/apa.17074","journal-title":"Acta Paediatr"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpam.2020.03.001","article-title":"The enigma of gastroesophageal reflux disease among convalescing infants in the NICU: It is time to rethink","volume":"7","author":"Badran EF","year":"2020","unstructured":"Badran EF, Jadcherla S. The enigma of gastroesophageal reflux disease among convalescing infants in the NICU: It is time to rethink. Int J Pediatr Adolesc Med. 2020, 7:26-30. 10.1016\/j.ijpam.2020.03.001","journal-title":"Int J Pediatr Adolesc Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001889","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)","volume":"66","author":"Rosen R","year":"2018","unstructured":"Rosen R, Vandenplas Y, Singendonk M, et al.. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2018, 66:516-54. 10.1097\/MPG.0000000000001889","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-3782(13)70005-7","article-title":"Neonatal apnea and gastroesophageal reflux (GER): is there a problem?","volume":"1","author":"Abu Jawdeh EG","year":"2013","unstructured":"Abu Jawdeh EG, Martin RJ. Neonatal apnea and gastroesophageal reflux (GER): is there a problem?. Early Hum Dev. 2013, 1:14-6. 10.1016\/S0378-3782(13)70005-7","journal-title":"Early Hum Dev"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-021-01821-y","article-title":"Anti-reflux medication use in preterm infants","volume":"92","author":"Binti Abdul Hamid H","year":"2022","unstructured":"Binti Abdul Hamid H, Szatkowski L, Budge H, Ojha S. Anti-reflux medication use in preterm infants. Pediatr Res. 2022, 92:520-5. 10.1038\/s41390-021-01821-y","journal-title":"Pediatr Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/pq9.0000000000000394","article-title":"Decreasing inappropriate use of antireflux medications by standardizing gastroesophageal reflux disease management in NICU","volume":"6","author":"Shakeel FM","year":"2021","unstructured":"Shakeel FM, Crews J, Jensen P, Ritchey A, Allen M, Mateus J, Machry J. Decreasing inappropriate use of antireflux medications by standardizing gastroesophageal reflux disease management in NICU. Pediatr Qual Saf. 2021, 6:e394. 10.1097\/pq9.0000000000000394","journal-title":"Pediatr Qual Saf"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/pq9.0000000000000303","article-title":"Reducing antacid use in a level IV NICU: a QI project to reduce morbidity","volume":"5","author":"Reinhart RM","year":"2020","unstructured":"Reinhart RM, McClary JD, Zhang M, Marasch JL, Hibbs AM, Nock ML. Reducing antacid use in a level IV NICU: a QI project to reduce morbidity. Pediatr Qual Saf. 2020, 5:e303. 10.1097\/pq9.0000000000000303","journal-title":"Pediatr Qual Saf"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-1715","article-title":"Implementation of a guideline to decrease use of acid-suppressing medications in the NICU","volume":"140","author":"Angelidou A","year":"2017","unstructured":"Angelidou A, Bell K, Gupta M, Tropea Leeman K, Hansen A. Implementation of a guideline to decrease use of acid-suppressing medications in the NICU. Pediatrics. 2017, 140:10.1542\/peds.2017-1715","journal-title":"Pediatrics"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpede.2021.03.001","article-title":"Stress ulcer prophylaxis for critically ill children: routine use needs to be re-examined","volume":"96","author":"Abu El-Ella SS","year":"2022","unstructured":"Abu El-Ella SS, El-Mekkawy MS, Mohamed Selim A. Stress ulcer prophylaxis for critically ill children: routine use needs to be re-examined. An Pediatr (Engl Ed). 2022, 96:402-9. 10.1016\/j.anpede.2021.03.001","journal-title":"An Pediatr (Engl Ed)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-016-0612-3","article-title":"Stress ulcer prophylaxis in critical illness: a Canadian survey","volume":"63","author":"Shears M","year":"2016","unstructured":"Shears M, Alhazzani W, Marshall JC, et al.. Stress ulcer prophylaxis in critical illness: a Canadian survey. Can J Anaesth. 2016, 63:718-24. 10.1007\/s12630-016-0612-3","journal-title":"Can J Anaesth"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-054527","article-title":"Stress ulcer prophylaxis for critical asthma","volume":"149","author":"Roberts AR","year":"2022","unstructured":"Roberts AR, Roddy M, Wilsey MJ, McKinley SD, Sanchez-Teppa B, Sochet AA. Stress ulcer prophylaxis for critical asthma. Pediatrics. 2022, 149:10.1542\/peds.2021-054527","journal-title":"Pediatrics"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2019.1614617","article-title":"Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding","volume":"57","author":"Sochet AA","year":"2020","unstructured":"Sochet AA, Son S, Ryan KS, et al.. Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding. J Asthma. 2020, 57:858-65. 10.1080\/02770903.2019.1614617","journal-title":"J Asthma"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-5005-8","article-title":"Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials","volume":"44","author":"Alhazzani W","year":"2018","unstructured":"Alhazzani W, Alshamsi F, Belley-Cote E, et al.. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2018, 44:1-11. 10.1007\/s00134-017-5005-8","journal-title":"Intensive Care Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199702000-00025","article-title":"A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients","volume":"25","author":"Kuusela AL","year":"1997","unstructured":"Kuusela AL, Ruuska T, Karikoski R, Laippala P, Ikonen RS, Janas M, M\u00e4ki M. A randomized, controlled study of prophylactic ranitidine in preventing stress-induced gastric mucosal lesions in neonatal intensive care unit patients. Crit Care Med. 1997, 25:346-51. 10.1097\/00003246-199702000-00025","journal-title":"Crit Care Med"},{"key":"ref46","article-title":"Stress associated gastric bleeding in newborn--role of ranitidine","volume":"28","author":"Sarna MS","year":"1991","unstructured":"Sarna MS, Saili A, Dutta AK, Sharma D. Stress associated gastric bleeding in newborn--role of ranitidine. Indian Pediatr. 1991, 28:1305-8.","journal-title":"Indian Pediatr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199208000-00003","article-title":"Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and sucralfate. The Gastrointestinal Hemorrhage Study Group","volume":"20","author":"L\u00f3pez-Herce J","year":"1992","unstructured":"L\u00f3pez-Herce J, Dorao P, Elola P, Delgado MA, Ruza F, Madero R. Frequency and prophylaxis of upper gastrointestinal hemorrhage in critically ill children: a prospective study comparing the efficacy of almagate, ranitidine, and sucralfate. The Gastrointestinal Hemorrhage Study Group. Crit Care Med. 1992, 20:1082-9. 10.1097\/00003246-199208000-00003","journal-title":"Crit Care Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803193381203","article-title":"A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group","volume":"338","author":"Cook D","year":"1998","unstructured":"Cook D, Guyatt G, Marshall J, et al.. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med. 1998, 338:791-7. 10.1056\/NEJM199803193381203","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03545.x","article-title":"Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects","volume":"27","author":"Suzuki T","year":"2008","unstructured":"Suzuki T, Yamaguchi T, Odaka T, Kobayashi M, Seza A, Kouzu T, Yokosuka O. Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: cross-over test to assess the early effects. Aliment Pharmacol Ther. 2008, 27:66-71. 10.1111\/j.1365-2036.2007.03545.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i19.2390","article-title":"A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease","volume":"18","author":"Kobeissy AA","year":"2012","unstructured":"Kobeissy AA, Hashash JG, Jamali FR, et al.. A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease. World J Gastroenterol. 2012, 18:2390-5. 10.3748\/wjg.v18.i19.2390","journal-title":"World J Gastroenterol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-021-2400-6","article-title":"Diagnosis and management of gastroesophageal reflux disease in children: recommendations of pediatric gastroenterology chapter of Indian academy of pediatrics, Indian society of pediatric gastroenterology, hepatology and nutrition (ISPGHAN)","volume":"58","author":"Mohan N","year":"2021","unstructured":"Mohan N, Matthai J, Bolia R, et al.. Diagnosis and management of gastroesophageal reflux disease in children: recommendations of pediatric gastroenterology chapter of Indian academy of pediatrics, Indian society of pediatric gastroenterology, hepatology and nutrition (ISPGHAN). Indian Pediatr. 2021, 58:1163-70. 10.1007\/s13312-021-2400-6","journal-title":"Indian Pediatr"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01243.x","article-title":"Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux","volume":"16","author":"Orenstein SR","year":"2002","unstructured":"Orenstein SR, Blumer JL, Faessel HM, et al.. Ranitidine, 75 mg, over-the-counter dose: pharmacokinetic and pharmacodynamic effects in children with symptoms of gastro-oesophageal reflux. Aliment Pharmacol Ther. 2002, 16:899-907. 10.1046\/j.1365-2036.2002.01243.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.221_a.x","article-title":"Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors","volume":"93","author":"Peghini PL","year":"1998","unstructured":"Peghini PL, Katz PO, Bracy NA, Castell DO. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors. Am J Gastroenterol. 1998, 93:763-7. 10.1111\/j.1572-0241.1998.221_a.x","journal-title":"Am J Gastroenterol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/01.mpg.0000189354.48043.4e","article-title":"Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors","volume":"42","author":"Pfefferkorn MD","year":"2006","unstructured":"Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors. J Pediatr Gastroenterol Nutr. 2006, 42:160-5. 10.1097\/01.mpg.0000189354.48043.4e","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1080\/13814780600757120","article-title":"Patients' views on dyspepsia and acid suppressant drug therapy in general practice","volume":"12","author":"Spijker-Huiges A","year":"2006","unstructured":"Spijker-Huiges A, Winters JC, Meyboom-De Jong B. Patients' views on dyspepsia and acid suppressant drug therapy in general practice. Eur J Gen Pract. 2006, 12:10-4. 10.1080\/13814780600757120","journal-title":"Eur J Gen Pract"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-021-00486-x","article-title":"Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health center","volume":"22","author":"Ayoub J","year":"2021","unstructured":"Ayoub J, McGregor JC, Castner RM, Singh H. Opportunities for successful de-escalation of proton pump inhibitors at a federally qualified health center. BMC Pharmacol Toxicol. 2021, 22:20. 10.1186\/s40360-021-00486-x","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2008.05861.x","article-title":"The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials","volume":"64","author":"Clark K","year":"2009","unstructured":"Clark K, Lam LT, Gibson S, Currow D. The effect of ranitidine versus proton pump inhibitors on gastric secretions: a meta-analysis of randomised control trials. Anaesthesia. 2009, 64:652-7. 10.1111\/j.1365-2044.2008.05861.x","journal-title":"Anaesthesia"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1007\/BF02810365","article-title":"Effect of pre-operative oral ranitidine on gastric pH and volume in children","volume":"55","author":"Indu","year":"1988","unstructured":"Indu, Batra YK, Saikia B. Effect of pre-operative oral ranitidine on gastric pH and volume in children. Indian J Pediatr. 1988, 55:420-3. 10.1007\/BF02810365","journal-title":"Indian J Pediatr"},{"key":"ref59","article-title":"The effect of pre-operative intake of oral water and ranitidine on gastric fluid volume and pH in children undergoing elective surgery","volume":"95","author":"Gombar S","year":"1997","unstructured":"Gombar S, Dureja J, Kiran S, Gombar K, Chhabra B. The effect of pre-operative intake of oral water and ranitidine on gastric fluid volume and pH in children undergoing elective surgery. J Indian Med Assoc. 1997, 95:166-8.","journal-title":"J Indian Med Assoc"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198909000-00001","article-title":"Effect of oral liquids and ranitidine on gastric fluid volume and pH in children undergoing outpatient surgery","volume":"71","author":"Sandhar BK","year":"1989","unstructured":"Sandhar BK, Goresky GV, Maltby JR, Shaffer EA. Effect of oral liquids and ranitidine on gastric fluid volume and pH in children undergoing outpatient surgery. Anesthesiology. 1989, 71:327-30. 10.1097\/00000542-198909000-00001","journal-title":"Anesthesiology"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082559","article-title":"Extra-esophageal presentation of gastroesophageal reflux disease: 2020 update","volume":"9","author":"Durazzo M","year":"2020","unstructured":"Durazzo M, Lupi G, Cicerchia F, et al.. Extra-esophageal presentation of gastroesophageal reflux disease: 2020 update. J Clin Med. 2020, 9:2559. 10.3390\/jcm9082559","journal-title":"J Clin Med"},{"key":"ref62","article-title":"Insight into the relationship between gastroesophageal reflux disease and asthma","volume":"10","author":"Ates F","year":"2014","unstructured":"Ates F, Vaezi MF. Insight into the relationship between gastroesophageal reflux disease and asthma. Gastroenterol Hepatol (N Y). 2014, 10:729-36.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2017-312890","article-title":"Respiratory manifestations of gastro-oesophageal reflux in children","volume":"103","author":"de Benedictis FM","year":"2018","unstructured":"de Benedictis FM, Bush A. Respiratory manifestations of gastro-oesophageal reflux in children. Arch Dis Child. 2018, 103:292-6. 10.1136\/archdischild-2017-312890","journal-title":"Arch Dis Child"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3390\/children9030336","article-title":"Gastroesophageal reflux in children with asthma","volume":"9","author":"Lupu VV","year":"2022","unstructured":"Lupu VV, Miron I, Tarca E, et al.. Gastroesophageal reflux in children with asthma. Children (Basel). 2022, 9:10.3390\/children9030336","journal-title":"Children (Basel)"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000705","article-title":"Gastroesophageal reflux and asthma: when, how, and why","volume":"21","author":"Paoletti G","year":"2021","unstructured":"Paoletti G, Melone G, Ferri S, et al.. Gastroesophageal reflux and asthma: when, how, and why. Curr Opin Allergy Clin Immunol. 2021, 21:52-8. 10.1097\/ACI.0000000000000705","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref66","unstructured":"Global initiative for asthma. (2024). Accessed. April 10, 2024: https:\/\/ginasthma.org\/reports\/."},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-101921","article-title":"Drug-induced dyspepsia","volume":"140","author":"Gross M","year":"2015","unstructured":"Gross M, Labenz J. Drug-induced dyspepsia. Dtsch Med Wochenschr. 2015, 140:728-33. 10.1055\/s-0041-101921","journal-title":"Dtsch Med Wochenschr"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2009.11.006","article-title":"Dyspepsia as an adverse effect of drugs","volume":"24","author":"Bytzer P","year":"2010","unstructured":"Bytzer P. Dyspepsia as an adverse effect of drugs. Best Pract Res Clin Gastroenterol. 2010, 24:109-20. 10.1016\/j.bpg.2009.11.006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.2174\/1381612821666150915105738","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDS) induced dyspepsia","volume":"21","author":"Yap PR","year":"2015","unstructured":"Yap PR, Goh KL. Non-steroidal anti-inflammatory drugs (NSAIDS) induced dyspepsia. Curr Pharm Des. 2015, 21:5073-81. 10.2174\/1381612821666150915105738","journal-title":"Curr Pharm Des"},{"key":"ref70","unstructured":"Rome Foundation. Rome IV Criteria. (2024). Accessed. April 21, 2024: https:\/\/theromefoundation.org\/rome-iv\/rome-iv-criteria\/."},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.015","article-title":"Functional disorders: children and adolescents","author":"Hyams JS","year":"2016","unstructured":"Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Functional disorders: children and adolescents. Gastroenterology. 2016, 10.1053\/j.gastro.2016.02.015","journal-title":"Gastroenterology"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.016","article-title":"Childhood functional gastrointestinal disorders: neonate\/toddler","author":"Benninga MA","year":"2016","unstructured":"Benninga MA, Faure C, Hyman PE, St James Roberts I, Schechter NL, Nurko S. Childhood functional gastrointestinal disorders: neonate\/toddler. Gastroenterology. 2016, 10.1053\/j.gastro.2016.02.016","journal-title":"Gastroenterology"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-022-00514-1","article-title":"Efficacy and safety of NSAIDS in infants: a comprehensive review of the literature of the past 20 years","volume":"24","author":"Ziesenitz VC","year":"2022","unstructured":"Ziesenitz VC, Welzel T, van Dyk M, Saur P, Gorenflo M, van den Anker JN. Efficacy and safety of NSAIDS in infants: a comprehensive review of the literature of the past 20 years. Paediatr Drugs. 2022, 24:603-55. 10.1007\/s40272-022-00514-1","journal-title":"Paediatr Drugs"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13132220","article-title":"Drug-associated gastropathy: diagnostic criteria","volume":"13","author":"Bordin DS","year":"2023","unstructured":"Bordin DS, Livzan MA, Gaus OV, Mozgovoi SI, Lanas A. Drug-associated gastropathy: diagnostic criteria. Diagnostics (Basel). 2023, 13:10.3390\/diagnostics13132220","journal-title":"Diagnostics (Basel)"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2515\/therapie:2007032","article-title":"Upper gastrointestinal complications associated with NSAIDs in children","volume":"62","author":"Autret-Leca E","year":"2007","unstructured":"Autret-Leca E, Bensouda-Grimaldi L, Maurage C, Jonville-Bera AP. Upper gastrointestinal complications associated with NSAIDs in children. Therapie. 2007, 62:173-6. 10.2515\/therapie:2007032","journal-title":"Therapie"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S156938","article-title":"Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits","volume":"11","author":"Gwee KA","year":"2018","unstructured":"Gwee KA, Goh V, Lima G, Setia S. Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits. J Pain Res. 2018, 11:361-74. 10.2147\/JPR.S156938","journal-title":"J Pain Res"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.2174\/1874306401408010085","article-title":"Inhaled corticosteroids and bone health","volume":"8","author":"Chee C","year":"2014","unstructured":"Chee C, Sellahewa L, Pappachan JM. Inhaled corticosteroids and bone health. Open Respir Med J. 2014, 8:85-92. 10.2174\/1874306401408010085","journal-title":"Open Respir Med J"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-023-00271-8","article-title":"Urticaria in childhood\u2014what\u2019s new?","volume":"32","author":"Brehler ACE","year":"2023","unstructured":"Brehler ACE, Bauer A, Wedi B. Urticaria in childhood\u2014what\u2019s new?. Allergo J Int. 2023, 32:318-25. 10.1007\/s40629-023-00271-8","journal-title":"Allergo J Int"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2017.9.3.189","article-title":"Prevalence and causes of childhood urticaria","volume":"9","author":"Shin M","year":"2017","unstructured":"Shin M, Lee S. Prevalence and causes of childhood urticaria. Allergy Asthma Immunol Res. 2017, 9:189-90. 10.4168\/aair.2017.9.3.189","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-022-00677-z","article-title":"Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride","volume":"18","author":"Ansotegui IJ","year":"2022","unstructured":"Ansotegui IJ, Bernstein JA, Canonica GW, et al.. Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. Allergy Asthma Clin Immunol. 2022, 18:41. 10.1186\/s13223-022-00677-z","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1111\/pai.12967","article-title":"Urticaria in children and adolescents: An updated review of the pathogenesis and management","volume":"30","author":"Kudryavtseva AV","year":"2019","unstructured":"Kudryavtseva AV, Neskorodova KA, Staubach P. Urticaria in children and adolescents: An updated review of the pathogenesis and management. Pediatr Allergy Immunol. 2019, 30:17-24. 10.1111\/pai.12967","journal-title":"Pediatr Allergy Immunol"},{"key":"ref82","article-title":"Antihistamines in urticaria and angioedema","volume":"17","author":"Black A","year":"2002","unstructured":"Black A, Greaves M. Antihistamines in urticaria and angioedema. Clin Allergy Immunol. 2002, 17:249-86.","journal-title":"Clin Allergy Immunol"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3390\/life14020164","article-title":"Combination of H1 and H2 histamine receptor antagonists: current knowledge and perspectives of a classic treatment strategy","volume":"14","author":"Kou E","year":"2024","unstructured":"Kou E, Zhang X, Dong B, Wang B, Zhu Y. Combination of H1 and H2 histamine receptor antagonists: current knowledge and perspectives of a classic treatment strategy. Life (Basel). 2024, 14:10.3390\/life14020164","journal-title":"Life (Basel)"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.19.06274-6","article-title":"Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine","volume":"154","author":"Curto-Barredo L","year":"2019","unstructured":"Curto-Barredo L, Gim\u00e9nez-Arnau AM. Treatment of chronic spontaneous urticaria with an inadequate response to H1-antihistamine. G Ital Dermatol Venereol. 2019, 154:444-56. 10.23736\/S0392-0488.19.06274-6","journal-title":"G Ital Dermatol Venereol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1978.tb01493.x","article-title":"Treatment of chronic idiopathic urticaria with combined H1 and H2 blockers","volume":"8","author":"Phanuphak P","year":"1978","unstructured":"Phanuphak P, Schocket A, Kohler PF. Treatment of chronic idiopathic urticaria with combined H1 and H2 blockers. Clin Allergy. 1978, 8:429-33. 10.1111\/j.1365-2222.1978.tb01493.x","journal-title":"Clin Allergy"},{"key":"ref86","article-title":"Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study","volume":"58","author":"Diller G","year":"1983","unstructured":"Diller G, Orfanos CE. Management of idiopathic urticaria with H1 + H2 antagonists. A crossover double blind long-term study. Z Hautkr. 1983, 58:785-93.","journal-title":"Z Hautkr"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1984.tb05706.x","article-title":"H2 blockers in chronic urticaria","volume":"23","author":"Singh G","year":"1984","unstructured":"Singh G. H2 blockers in chronic urticaria. Int J Dermatol. 1984, 23:627-8. 10.1111\/j.1365-4362.1984.tb05706.x","journal-title":"Int J Dermatol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/BF00981123","article-title":"Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients","volume":"31","author":"Paul E","year":"1986","unstructured":"Paul E, B\u00f6deker RH. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. Eur J Clin Pharmacol. 1986, 31:277-80. 10.1007\/BF00981123","journal-title":"Eur J Clin Pharmacol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.800183","article-title":"Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria","volume":"24","author":"Ogawa Y","year":"2013","unstructured":"Ogawa Y, Ichinokawa Y, Hiruma M, Machida Y, Funakushi N, Sadamasa H, Hiruma M. Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria. J Dermatolog Treat. 2013, 24:463-5. 10.3109\/09546634.2013.800183","journal-title":"J Dermatolog Treat"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008596.pub2","article-title":"Histamine H2-receptor antagonists for urticaria","volume":"2012","author":"Fedorowicz Z","year":"2012","unstructured":"Fedorowicz Z, van Zuuren EJ, Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev. 2012, 2012:CD008596. 10.1002\/14651858.CD008596.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/all.15090. Epub 2021 Oct 20","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier T","year":"2022","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al.. The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022, 77:734-66. 10.1111\/all.15090. Epub 2021 Oct 20","journal-title":"Allergy"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_307_22","article-title":"Diagnosis and management of urticaria in INDIAN settings: skin allergy research society\u2019s guideline-2022","volume":"67","author":"Godse K","year":"2022","unstructured":"Godse K, Patil A, De A, et al.. Diagnosis and management of urticaria in INDIAN settings: skin allergy research society\u2019s guideline-2022. Indian J Dermatol. 2022, 67:732-43. 10.4103\/ijd.ijd_307_22","journal-title":"Indian J Dermatol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1177\/2053951717743530","article-title":"Clinical practice guideline for diagnosis and management of urticaria","volume":"34","author":"Kulthanan K","year":"2016","unstructured":"Kulthanan K, Tuchinda P, Chularojanamontri L, et al.. Clinical practice guideline for diagnosis and management of urticaria. Asian Pac J Allergy Immunol. 2016, 34:190-200. 10.1177\/2053951717743530","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/351011-evidence-based-review-by-a-multidisciplinary-team-of-pediatricians-on-the-use-of-gastric-acid-reducing-medications-in-children-indian-perspectives","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T12:19:10Z","timestamp":1746620350000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/351011-evidence-based-review-by-a-multidisciplinary-team-of-pediatricians-on-the-use-of-gastric-acid-reducing-medications-in-children-indian-perspectives"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":93,"URL":"https:\/\/doi.org\/10.7759\/cureus.83653","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,7]]}}}